by lythamcorp | Oct 24, 2024 | Healthcare, Iradimed News
WINTER SPRINGS, Fla., Oct. 24, 2024 — IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2024 third quarter financial results before the market opens on Thursday, October 31, 2024. Iradimed management will host a conference...
by lythamcorp | Oct 24, 2024 | Cadrenal Therapeutics, Cadrenal Therapeutics News, Healthcare
PONTE VEDRA, Fla., Oct. 24, 2024 — Cadrenal Therapeutics, Inc., (Nasdaq: CVKD) (the “Company” or “Cadrenal”), a late-stage biopharmaceutical company developing tecarfarin, a new vitamin K antagonist (VKA) designed to offer safer, superior...
by lythamcorp | Oct 24, 2024 | ChromaDex News, Consumer
LOS ANGELES – ChromaDex Corp. (NASDAQ:CDXC), the global authority on nicotinamide adenine dinucleotide (NAD+) research with a focus on healthy aging, announced that it will hold a conference call on Wednesday, November 6, 2024 at 4:30 p.m. ET. to discuss its...
by lythamcorp | Oct 24, 2024 | NAYA News
SARASOTA, Fla. and MIAMI, Oct. 24, 2024 — NAYA Biosciences (“NAYA”) (NASDAQ: NAYA), a life science portfolio company dedicated to bringing breakthrough treatments to patients in oncology, autoimmune diseases, and fertility, today announced an update...
by lythamcorp | Oct 23, 2024 | Industrials, S&W Seed Co, SW Seed News
LONGMONT, Colo., Oct. 23, 2024 — S&W Seed Company (Nasdaq: SANW) announced that, on October 17, 2024, the Company received a notice from the Listing Qualifications Staff of The Nasdaq Stock Market (Nasdaq), advising the Company that its failure to timely...